Drug Registration in Brazil : DDReg Pharma
Drug Registration in Brazil is a critical step for pharmaceutical companies aiming to access Latin America’s largest healthcare market. ANVISA, Brazil’s regulatory authority, oversees the entire approval process. Understanding its pathways can help companies streamline submissions, reduce delays, and achieve faster market entry.